American Bio Medica Corporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 1.758 million compared to USD 958,000 a year ago. Operating income was USD 16,000 compared to operating loss of USD 155,000 a year ago. Net loss was USD 21,000 compared to USD 56,000 a year ago. For the half year, sales was USD 2.486 million compared to USD 1.880 million a year ago. Operating loss was USD 255,000 compared to USD 329,000 a year ago. Net loss was USD 346,000 compared to USD 296,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.